$DHSep 2, 2026, 12:32 PMAI processed
Definitive Healthcare names Clay Ritchey as CEO, effective Sept. 8, 2026
AI Summary
Definitive Healthcare (NASDAQ: DH) appointed Clay Ritchey as CEO effective Sept. 8, 2026, replacing Kevin Coop who departed Aug. 31, 2026. Ritchey — a 25+ year healthcare data executive who most recently led Verato and previously ran Evariant — said he'll push to accelerate a return to growth and roll out an AI-powered platform that pairs the company's proprietary datasets with conversational AI and workflows.
Positives
- New CEO has 25+ years in healthcare data/technology with prior CEO roles (Verato, Evariant), signaling relevant experience
- Management emphasizes a growth push and an upcoming AI-powered platform that could increase product differentiation
- CEO transition is immediate with a Sept. 8 start date, reducing leadership vacancy duration
Negatives
- Release gives no concrete timeline, milestones, or financial guidance for the AI platform or growth targets
- Previous CEO departed after a relatively recent tenure (served since June 2024), indicating recent leadership turnover
- Company reiterates broad forward‑looking risk factors including execution, data quality, and market conditions